2021
Redo‐transcatheter aortic valve replacement with the supra‐annular, self‐expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry
Attizzani GF, Dallan LAP, Forrest JK, Reardon MJ, Szeto WY, Liu F, Pelletier M. Redo‐transcatheter aortic valve replacement with the supra‐annular, self‐expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry. Catheterization And Cardiovascular Interventions 2021, 99: 869-876. PMID: 34533891, DOI: 10.1002/ccd.29941.Peer-Reviewed Original ResearchConceptsTranscatheter Valve Therapy RegistryTranscatheter aortic valveRedo-TAVRTVT RegistryRedo transcatheter aortic valve replacementBetter short-term outcomesTotal aortic regurgitationAortic valve replacementLow-risk patientsShort-term outcomesHospital mortalityIndex hospitalizationAortic regurgitationValve replacementDevice successEvolut RSafety profileMyocardial infarctionAortic valveEvolut PROPatientsRegistryMean gradientOutcomesEvolut
2020
TCT CONNECT-87 Redo Transcatheter Aortic Valve Replacement With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the TVT Registry
Attizzani G, Dallan L, Pelletier M, Deeb G, Forrest J, Reardon M, Popma J. TCT CONNECT-87 Redo Transcatheter Aortic Valve Replacement With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the TVT Registry. Journal Of The American College Of Cardiology 2020, 76: b38-b39. DOI: 10.1016/j.jacc.2020.09.101.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply